1. Home
  2. CRDL vs HOFT Comparison

CRDL vs HOFT Comparison

Compare CRDL & HOFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.31

Market Cap

154.1M

Sector

Health Care

ML Signal

HOLD

Logo Hooker Furnishings Corporation

HOFT

Hooker Furnishings Corporation

HOLD

Current Price

$13.31

Market Cap

144.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDL
HOFT
Founded
2017
1924
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
154.1M
144.6M
IPO Year
2017
1999

Fundamental Metrics

Financial Performance
Metric
CRDL
HOFT
Price
$1.31
$13.31
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
653.6K
47.2K
Earning Date
05-14-2026
04-16-2026
Dividend Yield
N/A
3.79%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$278,139,000.00
Revenue This Year
N/A
$17.37
Revenue Next Year
N/A
$9.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$8.62
52 Week High
$1.71
$15.99

Technical Indicators

Market Signals
Indicator
CRDL
HOFT
Relative Strength Index (RSI) 49.10 55.76
Support Level $0.95 $11.95
Resistance Level $1.43 $13.47
Average True Range (ATR) 0.10 0.75
MACD -0.02 0.04
Stochastic Oscillator 12.50 82.05

Price Performance

Historical Comparison
CRDL
HOFT

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

About HOFT Hooker Furnishings Corporation

Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.

Share on Social Networks: